Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

577 Articles

Lee Jackson | Feb 11, 2020 at 7:15 AM EST

5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher

24/7 Wall St. screened the Merrill Lynch health care research database looking for large pharmaceutical leaders that also pay solid…

Chris Lange | Feb 2, 2020 at 7:05 AM EST

Alphabet, Disney, Ford, Twitter, Uber and More Major Earnings Coming This Week

24/7 Wall St. has put together a preview of Disney, Ford, Merck, Uber and some of the other most anticipated…

Chris Lange | Jan 28, 2020 at 9:35 AM EST

Short Sellers Can’t Make Up Their Mind on Big Pharma

The January 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jan 13, 2020 at 9:40 AM EST

Short Sellers Shy Away From Big Pharma

The December 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Dec 26, 2019 at 8:55 AM EST

Big Pharma Short Sellers Get Selective

The December 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Dec 13, 2019 at 9:55 AM EST

Why Bristol-Myers Squibb Could Be the Best Large-Cap Pharmaceutical Stock for 2020

Independent research firm Argus sees better than 25% potential upside for Bristol-Myers Squibb in the coming year.

Jon C. Ogg | Dec 13, 2019 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap, Wayfair and More

The top analyst upgrades, downgrades and initiations for Friday included Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle,…

Chris Lange | Dec 11, 2019 at 9:45 AM EST

Big Pharma Short Sellers Grow More Selective

The November 29 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Nov 27, 2019 at 9:00 AM EST

Big Pharma Short Sellers Hike Their Bets

The November 15 short interest data have been compared with the previous figures, and short interest in most of these…

Paul Ausick | Nov 26, 2019 at 12:34 PM EST

Starboard Value Stake Momentarily Shakes Up CVS

A report that activist investor firm Starboard Value had taken a stake in CVS momentarily lifted the drugstore and health…

Chris Lange | Nov 12, 2019 at 8:50 AM EST

Big Pharma Scares Off Short Sellers

The October 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Oct 25, 2019 at 9:59 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Pharma

The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Oct 10, 2019 at 9:40 AM EDT

Big Pharma Sees Rising Tide in Short Interest

The September 30 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Sep 25, 2019 at 9:20 AM EDT

Short Sellers Grow More Selective in Big Pharma

The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Sep 12, 2019 at 8:35 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Pharma

The August 30 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 10 11 12 13 14 … 39

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher

Alphabet, Disney, Ford, Twitter, Uber and More Major Earnings Coming This Week

Short Sellers Can’t Make Up Their Mind on Big Pharma

Short Sellers Shy Away From Big Pharma

Big Pharma Short Sellers Get Selective

Why Bristol-Myers Squibb Could Be the Best Large-Cap Pharmaceutical Stock for 2020

Top Analyst Upgrades and Downgrades: Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap, Wayfair and More

Big Pharma Short Sellers Grow More Selective

Big Pharma Short Sellers Hike Their Bets

Starboard Value Stake Momentarily Shakes Up CVS

Big Pharma Scares Off Short Sellers

Short Sellers Can’t Make Up Their Minds on Big Pharma

Big Pharma Sees Rising Tide in Short Interest

Short Sellers Grow More Selective in Big Pharma

Short Sellers Can’t Make Up Their Minds on Big Pharma

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher

Alphabet, Disney, Ford, Twitter, Uber and More Major Earnings Coming This Week

Short Sellers Can’t Make Up Their Mind on Big Pharma

Short Sellers Shy Away From Big Pharma

Big Pharma Short Sellers Get Selective

Why Bristol-Myers Squibb Could Be the Best Large-Cap Pharmaceutical Stock for 2020

Top Analyst Upgrades and Downgrades: Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap, Wayfair and More

Big Pharma Short Sellers Grow More Selective

Big Pharma Short Sellers Hike Their Bets

Starboard Value Stake Momentarily Shakes Up CVS

Big Pharma Scares Off Short Sellers

Short Sellers Can’t Make Up Their Minds on Big Pharma

Big Pharma Sees Rising Tide in Short Interest

Short Sellers Grow More Selective in Big Pharma

Short Sellers Can’t Make Up Their Minds on Big Pharma

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do